STOCK TITAN

NHC Reports 2024 Year End Earnings

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags

National HealthCare (NYSE American: NHC) reported strong financial results for 2024, with net operating revenues and grant income reaching $1.31 billion, a 14.5% increase from 2023's $1.14 billion. The growth was driven by a 9.4% increase in same-facility revenues and the strategic acquisition of White Oak Manor on August 1, 2024, which added 22 healthcare operations to NHC's portfolio.

The company's GAAP net income for 2024 rose to $101.9 million ($6.53 per diluted share), up from $66.8 million ($4.34 per diluted share) in 2023. Adjusted net income, excluding unrealized gains in marketable equity securities, increased 39.9% to $76.9 million ($4.93 per diluted share) from $54.9 million ($3.55 per diluted share) in 2023.

National HealthCare (NYSE American: NHC) ha riportato risultati finanziari solidi per il 2024, con ricavi operativi netti e reddito da sovvenzioni che hanno raggiunto 1,31 miliardi di dollari, un incremento del 14,5% rispetto ai 1,14 miliardi di dollari del 2023. La crescita è stata guidata da un incremento del 9,4% nei ricavi delle stesse strutture e dall'acquisizione strategica di White Oak Manor il 1° agosto 2024, che ha aggiunto 22 operazioni sanitarie al portafoglio di NHC.

Il reddito netto GAAP dell'azienda per il 2024 è salito a 101,9 milioni di dollari (6,53 dollari per azione diluita), in aumento rispetto ai 66,8 milioni di dollari (4,34 dollari per azione diluita) del 2023. Il reddito netto rettificato, escludendo i guadagni non realizzati in titoli azionari commerciabili, è aumentato del 39,9% a 76,9 milioni di dollari (4,93 dollari per azione diluita) rispetto ai 54,9 milioni di dollari (3,55 dollari per azione diluita) del 2023.

National HealthCare (NYSE American: NHC) reportó resultados financieros sólidos para 2024, con ingresos operativos netos e ingresos de subvenciones alcanzando 1.31 mil millones de dólares, un aumento del 14.5% en comparación con los 1.14 mil millones de dólares de 2023. El crecimiento fue impulsado por un aumento del 9.4% en los ingresos de las mismas instalaciones y la adquisición estratégica de White Oak Manor el 1 de agosto de 2024, que añadió 22 operaciones de atención médica al portafolio de NHC.

El ingreso neto GAAP de la empresa para 2024 aumentó a 101.9 millones de dólares (6.53 dólares por acción diluida), en comparación con los 66.8 millones de dólares (4.34 dólares por acción diluida) en 2023. El ingreso neto ajustado, excluyendo las ganancias no realizadas en valores de acciones negociables, aumentó un 39.9% a 76.9 millones de dólares (4.93 dólares por acción diluida) desde 54.9 millones de dólares (3.55 dólares por acción diluida) en 2023.

National HealthCare (NYSE American: NHC)는 2024년 강력한 재무 결과를 보고했으며, 순 운영 수익 및 보조금 수익이 13억 1천만 달러에 도달하여 2023년의 11억 4천만 달러에 비해 14.5% 증가했습니다. 이 성장은 동일 시설 수익 9.4% 증가와 2024년 8월 1일 White Oak Manor의 전략적 인수에 의해 주도되었으며, 이는 NHC의 포트폴리오에 22개의 의료 운영을 추가했습니다.

회사의 2024년 GAAP 순이익은 1억 1천9백만 달러 (희석 주당 6.53달러)로 증가했으며, 2023년의 6천6백80만 달러 (희석 주당 4.34달러)에서 증가했습니다. 시장성 있는 주식 증권의 미실현 이익을 제외한 조정 순이익은 39.9% 증가하여 2023년의 5천4백90만 달러 (희석 주당 3.55달러)에서 7천6백90만 달러 (희석 주당 4.93달러)로 증가했습니다.

National HealthCare (NYSE American: NHC) a annoncé des résultats financiers solides pour 2024, avec des revenus d'exploitation nets et des revenus de subventions atteignant 1,31 milliard de dollars, soit une augmentation de 14,5 % par rapport aux 1,14 milliard de dollars de 2023. La croissance a été soutenue par une augmentation de 9,4 % des revenus des mêmes établissements et l'acquisition stratégique de White Oak Manor le 1er août 2024, qui a ajouté 22 opérations de soins de santé au portefeuille de NHC.

Le revenu net GAAP de l'entreprise pour 2024 a augmenté à 101,9 millions de dollars (6,53 dollars par action diluée), contre 66,8 millions de dollars (4,34 dollars par action diluée) en 2023. Le revenu net ajusté, excluant les gains non réalisés sur titres de participation négociables, a augmenté de 39,9 % pour atteindre 76,9 millions de dollars (4,93 dollars par action diluée) contre 54,9 millions de dollars (3,55 dollars par action diluée) en 2023.

National HealthCare (NYSE American: NHC) berichtete für 2024 über starke finanzielle Ergebnisse, mit Nettobetriebseinnahmen und Zuschusseinnahmen von 1,31 Milliarden US-Dollar, was einem Anstieg von 14,5% gegenüber 1,14 Milliarden US-Dollar im Jahr 2023 entspricht. Das Wachstum wurde durch einen 9,4%igen Anstieg der Einnahmen aus denselben Einrichtungen und die strategische Akquisition von White Oak Manor am 1. August 2024, die 22 Gesundheitsbetriebe zum Portfolio von NHC hinzufügte, vorangetrieben.

Das GAAP-Nettoeinkommen des Unternehmens für 2024 stieg auf 101,9 Millionen US-Dollar (6,53 US-Dollar pro verwässerter Aktie), gegenüber 66,8 Millionen US-Dollar (4,34 US-Dollar pro verwässerter Aktie) im Jahr 2023. Das bereinigte Nettoeinkommen, ohne nicht realisierte Gewinne aus handelbaren Eigenkapitalwertpapieren, stieg um 39,9% auf 76,9 Millionen US-Dollar (4,93 US-Dollar pro verwässerter Aktie) von 54,9 Millionen US-Dollar (3,55 US-Dollar pro verwässerter Aktie) im Jahr 2023.

Positive
  • 14.5% increase in annual revenue to $1.31B
  • 39.9% growth in adjusted net income to $76.9M
  • 9.4% increase in same-facility revenues
  • Strategic expansion through White Oak Manor acquisition (22 facilities)
  • 62.7% increase in Q4 adjusted net income
Negative
  • Q4 2024 GAAP net income declined to $6.1M from $28.4M in Q4 2023

Insights

National HealthCare 's 2024 financial results demonstrate exceptional growth across multiple dimensions, with revenues reaching $1.31 billion (up 14.5%) and adjusted net income surging 39.9% to $76.9 million. This performance significantly outpaces typical growth rates in the senior healthcare sector, which generally range from 3-5% annually.

The 9.4% same-facility revenue growth is particularly impressive, reflecting strong organic performance independent of acquisitions. This suggests substantial operational improvements in existing facilities, likely through a combination of increased occupancy rates, higher reimbursement rates, and potentially expanded service offerings.

The August 2024 White Oak Manor acquisition represents a transformative expansion, adding 22 facilities to NHC's portfolio. Based on the fourth quarter results, this acquisition appears to be integrating successfully, contributing to the remarkable 62.7% increase in Q4 adjusted net income. The diversified nature of these new assets (spanning skilled nursing, assisted living, independent living, and pharmacy services) strengthens NHC's integrated care model and reduces reimbursement risk through service diversification.

The substantial gap between GAAP and adjusted earnings warrants attention. While adjusted earnings grew impressively, GAAP quarterly earnings actually declined from $28.4 million to $6.1 million year-over-year. This divergence likely stems from significant unrealized losses in their equity portfolio during Q4 2024, contrasting with gains in the prior year period. Investors should view this as a financial reporting matter rather than an operational concern.

These results position NHC favorably in the growing senior healthcare market, with demonstrated ability to drive both organic growth and successfully integrate acquisitions. The company's expanded footprint should provide economies of scale and enhanced geographic coverage, potentially supporting continued margin expansion in 2025.

MURFREESBORO, Tenn.--(BUSINESS WIRE)-- National HealthCare Corporation (NYSE American: NHC), the nation's oldest publicly traded senior health care company, announced today net operating revenues and grant income for the year ended December 31, 2024 totaled $1,307,382,000 compared to $1,141,544,000 for the year ended December 31, 2023, an increase of 14.5%. The increase in net operating revenues for the 2024 year compared to the 2023 year was due to a 9.4% increase in same-facility net operating revenues, as well as the August 1, 2024 acquisition of White Oak Manor (“White Oak”). The White Oak operations consist of 22 healthcare operations, which includes 15 skilled nursing facilities, two assisted living facilities, four independent living facilities, and a long-term care pharmacy.

For the year ended December 31, 2024, the reported GAAP net income attributable to NHC was $101,927,000 compared to $66,798,000 for the 2023 year. Excluding the unrealized gains in our marketable equity securities portfolio and other non-GAAP adjustments, adjusted net income for the year ended December 31, 2024 was $76,862,000 compared to $54,934,000 for the 2023 year (*), an increase of 39.9%. GAAP diluted earnings per share were $6.53 and $4.34 for the years ended December 31, 2024 and 2023, respectively. Adjusted diluted earnings per share were $4.93 and $3.55 for the years ended December 31, 2024 and 2023, respectively (*).

For the quarter ended December 31, 2024, the reported GAAP net income attributable to NHC was $6,081,000 compared to $28,406,000 for the same period in 2023. Excluding the unrealized gains or losses in our marketable equity securities portfolio and other non-GAAP adjustments, adjusted net income for the quarter ended December 31, 2024 was $25,954,000 compared to $15,955,000 for the same period in 2023, an increase of 62.7% (*). The GAAP diluted earnings per share were $0.39 and $1.83 for the quarters ended December 31, 2024 and 2023, respectively. Adjusted diluted earnings per share were $1.66 and $1.03 for the quarters ended December 31, 2024 and 2023, respectively (*).

(*) - See the tables below that provide a reconciliation of GAAP to non-GAAP items.

About NHC

NHC affiliates operate for themselves and third parties 80 skilled nursing facilities with 10,341 beds. NHC affiliates also operate 26 assisted living communities with 1,413 units, nine independent living communities with 777 units, three behavioral health hospitals, 34 homecare agencies, and 33 hospice agencies. NHC’s other services include Alzheimer’s and memory care units, pharmacy services, a rehabilitation services company, and providing management and accounting services to third party post-acute operators. Other information about the company can be found on our web site at www.nhccare.com.

Non-GAAP Financial Presentation

The Company is providing certain non-GAAP financial measures as the Company believes that these figures are helpful in allowing investors to more accurately assess the ongoing nature of the Company’s operations and measure the Company’s performance more consistently across periods. Therefore, the Company believes this information is meaningful in addition to the information contained in the GAAP presentation of financial information. The presentation of this additional non-GAAP financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP.

Forward-Looking Statements

Statements in this press release that are not historical facts are forward-looking statements. NHC cautions investors that any forward-looking statements made involve risks and uncertainties and are not guarantees of future performance. The risks and uncertainties are detailed from time to time in reports filed by NHC with the S.E.C., including Forms 8-K, 10-Q, and 10-K. All forward-looking statements represent NHC’s best judgment as of the date of this release.

Consolidated Statements of Operations
(in thousands, except share and per share amounts)
Three Months Ended Years Ended
December 31 December 31

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Revenues and grant income:
Net patient revenues

$

357,344

 

$

282,997

 

$

1,251,759

 

$

1,087,614

 

Other revenues

 

12,006

 

 

17,917

 

 

46,178

 

 

53,930

 

Government stimulus income

 

-

 

 

-

 

 

9,445

 

 

-

 

Net operating revenues and grant income

 

369,350

 

 

300,914

 

 

1,307,382

 

 

1,141,544

 

 
Costs and expenses:
Salaries, wages and benefits

 

234,321

 

 

186,562

 

 

810,930

 

 

712,344

 

Other operating

 

83,298

 

 

70,970

 

 

321,390

 

 

288,183

 

Facility rent

 

11,378

 

 

11,438

 

 

43,182

 

 

41,525

 

Depreciation and amortization

 

11,442

 

 

11,768

 

 

41,985

 

 

42,034

 

Interest

 

2,347

 

 

56

 

 

4,135

 

 

324

 

Total costs and expenses

 

342,786

 

 

280,794

 

 

1,221,622

 

 

1,084,410

 

 
Income from operations

 

26,564

 

 

20,120

 

 

85,760

 

 

57,134

 

 
Non-operating income

 

4,825

 

 

4,544

 

 

19,690

 

 

16,660

 

Unrealized gains/(losses) on marketable equity securities

 

(25,332

)

 

12,001

 

 

30,958

 

 

14,944

 

 
Income before income taxes

 

6,057

 

 

36,665

 

 

136,408

 

 

88,738

 

Income tax provision

 

(28

)

 

(8,700

)

 

(34,322

)

 

(23,450

)

Net income

 

6,029

 

 

27,965

 

 

102,086

 

 

65,288

 

 
Net (income)/loss attributable to noncontrolling interest

 

52

 

 

441

 

 

(159

)

 

1,510

 

 
Net income attributable to National HealthCare Corporation

$

6,081

 

$

28,406

 

$

101,927

 

$

66,798

 

 
Net income per common share
Basic

$

0.39

 

$

1.86

 

$

6.62

 

$

4.36

 

Diluted

$

0.39

 

$

1.83

 

$

6.53

 

$

4.34

 

 
Weighted average common shares outstanding
Basic

 

15,420,658

 

 

15,306,253

 

 

15,393,782

 

 

15,310,142

 

Diluted

 

15,665,025

 

 

15,486,573

 

 

15,598,528

 

 

15,377,343

 

 
Dividends declared per common share

$

0.61

 

$

0.59

 

$

2.42

 

$

2.34

 

 
 
Balance Sheet Data December 31 December 31
(in thousands)

 

2024

 

 

2023

 

 
Cash, cash equivalents and marketable securities

$

216,185

 

$

223,620

 

Restricted cash, cash equivalents and marketable securities

 

163,795

 

 

167,971

 

Current assets

 

424,408

 

 

406,235

 

Property and equipment, net

 

684,289

 

 

493,329

 

Total assets

 

1,524,429

 

 

1,310,796

 

Current liabilities, excluding long-term debt due within one year

 

227,297

 

 

214,476

 

Current and long-term debt

 

137,000

 

 

-

 

NHC stockholders' equity

 

980,161

 

 

908,752

 

 
Selected Operating Statistics
Three Months Ended Years Ended
December 31 December 31

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Skilled Nursing Per Diems:
Medicare

$

607.67

 

$

579.84

 

$

586.76

 

$

559.07

 

Managed Care

 

490.41

 

 

478.51

 

 

468.23

 

 

464.89

 

Medicaid

 

279.02

 

 

268.58

 

 

275.78

 

 

253.95

 

Private Pay and Other

 

321.12

 

 

290.85

 

 

316.80

 

 

282.14

 

 
Average Skilled Nursing Per Diem

$

350.72

 

$

337.57

 

(1)

$

346.46

 

(1)

$

324.53

 

(1)

 
Skilled Nursing Patient Days:
Medicare

 

84,809

 

 

79,025

 

 

320,524

 

 

318,253

 

Managed Care

 

76,996

 

 

62,031

 

 

276,019

 

 

242,023

 

Medicaid

 

374,755

 

 

288,538

 

 

1,281,020

 

 

1,140,612

 

Private Pay and Other

 

191,926

 

 

170,916

 

 

677,449

 

 

663,195

 

 
Total Skilled Nursing Patient Days

 

728,486

 

 

600,510

 

(1)

 

2,555,012

 

(1)

 

2,364,083

 

(1)

 
(1) NHC exited three skilled nursing facilities in Missouri on March 1, 2024. For the first quarter of 2024, the exited Missouri skilled nursing facilities had an average skilled nursing per diem of $259.56 and 20,267 patient days. For the three months ended December 31, 2023, the exited Missouri skilled nursing facilities had an average skilled nursing per diem of $253.84 and 31,761 patient days. For the year ended December 31, 2023, the exited Missouri skilled nursing facilities had an average skilled nursing per diem of $249.85 and 126,791 patient days.
 
The tables below provide reconciliations of GAAP to non-GAAP items (in thousands, except per share amounts):
Three Months Ended Years Ended
December 31 December 31

 

2024

 

 

2023

 

 

2024

 

 

2023

 

 
Net income attributable to National Healthcare Corporation

$

6,081

 

$

28,406

 

$

101,927

 

$

66,798

 

Non-GAAP adjustments
Unrealized (gains)/losses on marketable equity securities

 

25,332

 

 

(12,001

)

 

(30,958

)

 

(14,944

)

Gain on sale of property and equipment

 

-

 

 

(6,230

)

 

-

 

 

(6,230

)

Gain on sale of unconsolidated company

 

-

 

 

-

 

 

(1,024

)

 

-

 

Operating results for newly opened operations not at full capacity (2)

 

(10

)

 

742

 

 

130

 

 

2,359

 

Stock-based compensation expense

 

1,098

 

 

663

 

 

4,160

 

 

2,782

 

Acquisition-related expenses (3)

 

435

 

 

-

 

 

3,266

 

 

-

 

Employee retention credit

 

-

 

 

-

 

 

(9,445

)

 

-

 

Income tax provision on non-GAAP adjustments

 

(6,982

)

 

4,375

 

 

8,806

 

 

4,169

 

Non-GAAP Net income

$

25,954

 

$

15,955

 

$

76,862

 

$

54,934

 

 
GAAP diluted earnings per share

$

0.39

 

$

1.83

 

$

6.53

 

$

4.34

 

Non-GAAP adjustments
Unrealized (gains)/losses on marketable equity securities

 

1.20

 

 

(0.57

)

 

(1.47

)

 

(0.72

)

Gain on sale of property and equipment

 

-

 

 

(0.30

)

 

-

 

 

(0.30

)

Gain on sale of unconsolidated company

 

-

 

 

-

 

 

(0.05

)

 

-

 

Operating results for newly opened operations not at full capacity (2)

 

-

 

 

0.04

 

 

0.01

 

 

0.10

 

Stock-based compensation expense

 

0.05

 

 

0.03

 

 

0.20

 

 

0.13

 

Acquisition-related expenses (3)

 

0.02

 

 

-

 

 

0.16

 

 

-

 

Employee retention credit

 

-

 

 

-

 

 

(0.45

)

 

-

 

Non-GAAP diluted earnings per share

$

1.66

 

$

1.03

 

$

4.93

 

$

3.55

 

 
(2) The operating results for newly opened facilities or agencies not at full capacity include healthcare operations that are still considered in the start-up phase, which are two hospice agencies for the fourth quarter and year ended December 31, 3024. For the fourth quarter and year ended December 31, 2023, included are two behavioral health hospitals, two homecare agencies, and two hospice agencies.
(3) Represents expenses incurred to acquire the White Oak operations that are not capitalizable.

 

Brian F. Kidd, SVP/CFO

Phone: (615) 890-2020

Source: National HealthCare Corporation

FAQ

What was NHC's revenue growth in 2024 compared to 2023?

NHC's net operating revenues grew 14.5% to $1.31 billion in 2024, up from $1.14 billion in 2023.

How many facilities did NHC acquire through the White Oak Manor acquisition in 2024?

NHC acquired 22 healthcare operations from White Oak Manor, including 15 skilled nursing facilities, 2 assisted living facilities, 4 independent living facilities, and a long-term care pharmacy.

What was NHC's adjusted earnings per share for full-year 2024?

NHC's adjusted diluted earnings per share for 2024 was $4.93, compared to $3.55 in 2023.

How much did NHC's same-facility revenues increase in 2024?

NHC's same-facility net operating revenues increased by 9.4% in 2024.

What was NHC's net income growth in Q4 2024?

NHC's adjusted net income for Q4 2024 increased 62.7% to $25.95 million, compared to $15.96 million in Q4 2023.

National Health

NYSE:NHC

NHC Rankings

NHC Latest News

NHC Stock Data

1.45B
12.46M
19.2%
61.55%
2.23%
Medical Care Facilities
Services-skilled Nursing Care Facilities
Link
United States
MURFREESBORO